[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370010-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370010-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","construction-and-verification-of-a-prognostic-model-for-prostate-cancer-based-on-ribosome-biogenesis-related-genes","Construction and verification of a prognostic model for prostate cancer based on ribosome biogenesis-related genes","","Background Prostate cancer is prevalent and often aggressive, and the role of ribosome biogenesis-related genes in its prognosis remains insufficiently explored. This study investigates whether ribosome biogenesis-related gene expression patterns can serve as prognostic markers. Methods uses public transcriptomic datasets to identify prostate cancer–associated differential genes, select candidate regulatory genes, build a prognostic risk model, validate it, and perform enrichment, immune infiltration, and drug prediction analyses. Results SMARCA4, FBLL1, RRS1, and NVL form the prognostic signature and correlate with immune cell infiltration and pathway differences. RT-qPCR and Western Blot validate key gene expression. Conclusion The identified genes provide a new direction for clinical prognosis and treatment strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/construction-and-verification-of-a-prognostic-model-for-prostate-cancer-based-on-ribosome-biogenesis-related-genes/370010/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/construction-and-verification-of-a-prognostic-model-for-prostate-cancer-based-on-ribosome-biogenesis-related-genes/370010.png","ImageObject",300,407,{"name":42,"@type":43},"PakDamar76","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this study?","Question",{"text":63,"@type":64},"To construct and verify a prognostic model for prostate cancer based on ribosome biogenesis-related gene expression patterns, identifying candidate prognostic markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were prognostic candidate genes selected?",{"text":68,"@type":64},"The study used public transcriptomic data to find differential ly expressed genes associated with prostate cancer, then selected those that were also regulatory genes and applied regression analysis to determine prognostic significance.",{"name":70,"@type":61,"acceptedAnswer":71},"Which genes were identified as prognostic markers?",{"text":72,"@type":64},"SMARCA4, FBLL1, RRS1, and NVL were selected as prognostic genes, and a risk model based on them showed precision in evaluating prostate cancer risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370010,1790339618,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":33,"preview_urls":144},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Xie etal. BMC Medical Genomics (2025) 18:196 BMC Medical Genomics  \n[https://doi.org/10.1186/s12920-025-02262-w](https://doi.org/10.1186/s12920-025-02262-w)  \nRESEARCH Open Access  \nConstruction and verification of a prognostic  model for prostate cancer based on ribosome biogenesis-related genes  \nJiaWei Xie 1†, YanHong Tang2†, YuHang Wang3, Xin Gao4, FaJun Fu 1, YuMing Liu 1, Chen Yi 1, Gang Zhou 1, ZiJian Wang 1, Can Chen 1, PeiMin Jin 1, Yi Cai3* and JianJun Zhou 1*  \nAbstract  \nBackground Prostate cancer (PCa) is a prevalent and often aggressive malignancy. While ribosome production is a critical process in numerous cancers, the role of ribosome biogenesis-related genes (RB-RGs) in PCa remains underexplored. Therefore, this study aims to examine the expression characteristics of RB-RGs as potential prognostic markers in PCa.  \nMethods Transcriptomic data were obtained from public databases to pinpoint differential ly expressed genes (DEGs) associated with PCa. Among these, DEGs that were also identified as regulatory genes were selected as candidate genes and subjected to regression analysis to determine those with prognostic significance. A prognostic risk model was then created and subjected to validation. A standalone prognostic evaluation was performed. Additionally, analyses for enrichment, immune infiltration, and drug prediction were conducted for both high-and low-risk  \nPCa cohorts. Finally, the levels of the prognostic genes were validated through reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western Blot (WB) .  \nResults SMARCA4, FBLL1, RRS1, and NVL were selected as prognostic genes. A risk model, exhibited considerable precision in evaluating the risk of PCa. The risk score, in conjunction with the prostate-specific antigen (PSA) score and Gleason score, has been recognized as independent prognostic factors for PCa. Analysis of biological pathways indicated notable variations in pathways, especially the cell cycle, when comparing the high-and low-risk groups. The expression of prognostic genes demonstrated a correlation with the presence of 21 distinct types of immune cells, notably including type-17 T helper cells, within PCa samples. Furthermore, notable variations in the levels of target genes (AKT1, CDK1, HIF1A, NFKB1, SRC, and TRIM24) were detected between the high-and low-risk cohorts in relation to different chemotherapeutic agents. PCR analysis showed that NVL and SMARCA4 were significantly upregulated in PCa samples (p \u003C 0. 05), with no significant difference in RRS 1.  \n†JiaWei Xie andYanHong Tang contributed equally to this work.  \n*Correspondence: Yi Cai [cai-yi@csu.edu.cn](cai-yi@csu.edu.cn)[ ](cai-yi@csu.edu.cn)JianJun Zhou [zjj1228@163.com](zjj1228@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nXie et al. BMC Medical Genomics (2025) 18:196 Page 2 of 20  \nWB analysis s","cbCaibqDBdiJj6hH","https://ap.wps.com/l/cbCaibqDBdiJj6hH","pdf",15417768,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the main goal of this study?\",\"answer\":\"To construct and verify a prognostic model for prostate cancer based on ribosome biogenesis-related gene expression patterns, identifying candidate prognostic markers.\"},{\"question\":\"How were prognostic candidate genes selected?\",\"answer\":\"The study used public transcriptomic data to find differential ly expressed genes associated with prostate cancer, then selected those that were also regulatory genes and applied regression analysis to determine prognostic significance.\"},{\"question\":\"Which genes were identified as prognostic markers?\",\"answer\":\"SMARCA4, FBLL1, RRS1, and NVL were selected as prognostic genes, and a risk model based on them showed precision in evaluating prostate cancer risk.\"}]","Construction and verification of a prognostic model for prostate cancer based on ribosome biogenesis-related genes | PDF",1790186243,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f253244c5589c4898a78ff6a2aa59700.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9bf9a7de01424798e9e43d6529aa647.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00a8c077528d77bd1d175cf28953edf0.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73df6fdd75febef7d06607b9d3fcc10e.webp",980,1306]